Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SCL vs GRC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GRC Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)

GRC Overall Winner 6-Pillar Tally: SCL 3 – 3 GRC Matrix Metrics: SCL 4 – 6 GRC

As of Nov 20, 2026, The Gorman-Rupp Company Common Shares (GRC) is the stronger overall head-to-head candidate over Stepan Co. (SCL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). SCL carries a Unified Composite Score of 41.5/100 (SELL) at $63.48 (18.0x Forward P/E, 3.5% operating margin), whereas GRC carries 42.1/100 (HOLD) at $64.03 (19.8x Forward P/E, 16.0% operating margin).

  • Technical & Structure Timing Caution: SCL trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 40.5); meanwhile GRC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SCL vs GRC
SCL NYSE
Stepan Co.
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$63.48
-2.34% 1D
Market Cap $1.5B
TTM Revenue $2.53B
Forward P/E 18.0x
Beta / 30D Vol 0.55β · 32% Vol
Unified Composite Score
41.5 / 100 SELL
Tech 25.0 Fund 44.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 40.5 · SMA20: $67.16 · SMA50: $64.40
GRC NYSE Head-to-Head Winner
The Gorman-Rupp Company Common Shares
Pumps & Pumping Equipment
$64.03
-4.66% 1D
Market Cap $1.8B
TTM Revenue $722M
Forward P/E 19.8x
Beta / 30D Vol 1.31β · 44% Vol
Unified Composite Score
42.1 / 100 HOLD
Tech 29.0 Fund 50.0 Flow 59.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 30
RSI-14: 30.3 · SMA20: $70.89 · SMA50: $72.63

6-Pillar Scorecard Institutional Category Breakdown (SCL 3 – 3 GRC)

Columns: Metric · SCL · GRC
1. Valuation Multiples SCL
Forward P/E 18.0x 19.8x
Trailing P/E N/M 24.0x
PEG Ratio 1.75x 1.68x
EV / Revenue 0.8x 2.7x
2. Growth & Scale SCL
Revenue Growth (YoY) +17.3% +11.8%
Earnings Growth (YoY) +65.5% +99.5%
TTM Revenue (USD) $2.53B $722M
Market Cap $1.5B $1.8B
3. Profitability & Quality GRC
Gross Margin 12.0% 32.5%
Operating Margin 3.5% 16.0%
Net Profit Margin 0.2% 10.2%
Return on Equity (ROE) 0.4% 17.0%
4. Balance Sheet & Cash Flow GRC
Cash Generation (TTM) $4.6M $110M
Cash Flow Margin 0.2% 15.3%
Net Cash / Leverage $578M Net Debt (0.56x D/E) $191M Net Debt (0.54x D/E)
Dividend Yield 2.39% 1.11%
5. Options & Positioning SCL
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 33.5% (5th %ile) 38.5% (8th %ile)
Put/Call OI Skew N/A 3.00x (Put-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat GRC
OpEx & R&D Intensity 8.5% of Rev ($215M) 16.5% of Rev ($119M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Specialty Chemicals Operator Specialty Industrial Machinery Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SCL (4) vs GRC (6)
Institutional Metric SCL GRC Criterion Row Edge
Market Capitalization
Scale
$1.5B $1.8B Larger Scale GRC
Trailing P/E Ratio
Valuation
N/M 24.0x Lower Multiple GRC
Forward P/E Ratio
Valuation
18.0x 19.8x Lower Multiple SCL
Revenue Growth (YoY)
Growth
+17.3% +11.8% Higher Growth SCL
Operating Margin (TTM)
Profitability
3.5% 16.0% Higher Margin GRC
Net Profit Margin
Profitability
0.2% 10.2% Higher Margin GRC
Return on Equity (ROE)
Capital Efficiency
0.4% 17.0% Higher ROE GRC
52-Week Range Position
Momentum
70% ($42–$73) 42% ($43–$93) Stronger Trend SCL
Beta / 30D Volatility
Risk Regime
0.55β · 32% Vol 1.31β · 44% Vol Lower Realized Risk SCL
Unified Institutional Score
Composite Signal
41.5 / 100 (SELL) 42.1 / 100 (HOLD) Higher Composite GRC
Trailing 12M Revenue (USD)
Operating Scale
$2.53B $722M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
12.0% 32.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.75x PEG · 0.8x EV/Rev 1.68x PEG · 2.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$4.6M ($578M Net Debt (0.56x D/E)) $110M ($191M Net Debt (0.54x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SCL +7.39 pp
SCL: -1.31% · GRC: -8.7%
3M Horizon SCL +19.84 pp
SCL: +2.12% · GRC: -17.72%
6M Horizon SCL +33.79 pp
SCL: +21.91% · GRC: -11.88%
1Y Horizon SCL +2.97 pp
SCL: +49.79% · GRC: +46.82%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SCL Revenue GRC Revenue SCL Op. Margin GRC Op. Margin Margin Leader
FY2018 $1.99B $410M 7.5% 12.2% GRC
FY2019 $1.86B $400M 6.8% 11.0% GRC
FY2020 $1.87B $350M 9.2% 10.2% GRC
FY2021 $2.35B $380M 7.3% 10.4% GRC
FY2022 $2.77B $520M 7.5% 7.7% GRC
FY2023 $2.33B $660M 2.5% 13.2% GRC
FY2024 $2.18B $660M 3.2% 13.9% GRC
FY2025 $2.33B $680M 3.4% 14.0% GRC

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SCL CONSOLIDATION
81d in phase · OBV ACCUMULATION
Current IV 33.5%
IV Percentile 5th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SCL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GRC BREAKDOWN
104d in phase · OBV DISTRIBUTION
Current IV 38.5%
IV Percentile 8th %ile
Put/Call OI Skew 3.00x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact GRC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SCL Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $1.5B market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 8.5% of Rev ($215M)
90D Engineering Disclosures 0 Published
GRC Moat Profile Scale & Operating Efficiency Moat
Specialty Industrial Machinery Operator
Competes within the Specialty Industrial Machinery value chain with $1.8B market capitalization and 16.0% operating margin.
OpEx & R&D Reinvestment 16.5% of Rev ($119M)
90D Engineering Disclosures 0 Published

Investor FAQ SCL vs GRC Key Questions & Quantitative Answers

As of Nov 20, 2026, The Gorman-Rupp Company Common Shares (GRC) is the stronger overall head-to-head candidate over Stepan Co. (SCL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). SCL carries a Unified Composite Score of 41.5/100 (SELL) at $63.48 (18.0x Forward P/E, 3.5% operating margin), whereas GRC carries 42.1/100 (HOLD) at $64.03 (19.8x Forward P/E, 16.0% operating margin). Technical & Structure Timing Caution: SCL trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 40.5); meanwhile GRC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SCL leads the Growth & Scale pillar: SCL posts +17.3% YoY revenue growth and +65.5% YoY earnings growth on $2.53B TTM revenue (12.0% gross margin, 3.5% operating margin), compared with GRC at +11.8% YoY revenue growth and +99.5% YoY earnings growth on $722M TTM revenue (32.5% gross margin, 16.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SCL cumulative revenue shifted +17.1% while GRC shifted +65.9%. In operating R&D and SG&A reinvestment, SCL deploys 8.5% of Rev ($215M) (0 90-day corporate R&D disclosures) versus 16.5% of Rev ($119M) (0 disclosures) for GRC.

SCL screens cheaper on headline valuation multiples. SCL trades at 18.0x Forward P/E, N/M Trailing P/E, 1.75x PEG, and 0.8x EV/Revenue (0.2% FCF margin), whereas GRC trades at 19.8x Forward P/E, 24.0x Trailing P/E, 1.68x PEG, and 2.7x EV/Revenue (15.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SCL (0.4% ROE) versus GRC (17.0% ROE) capital efficiency.

In options market volatility and institutional positioning, SCL carries 33.5% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.55β · 32% Vol realized risk). By comparison, GRC carries 38.5% implied volatility (8th %ile, Compressed (<25th %ile)), a 3.00x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.31β · 44% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.